# Investigate Safety, Tolerability, PK/PD of J2H-1702 in Healthy Females

> **NCT06308874** · PHASE1 · COMPLETED · sponsor: **J2H Biotech** · enrollment: 16 (actual)

## Conditions studied

- Non-alcoholic Steatohepatitis

## Interventions

- **DRUG:** Amg dose administration group
- **DRUG:** Amg dose administration group- Placebo
- **DRUG:** Bmg dose administration group
- **DRUG:** Bmg dose administration group- Placebo

## Key facts

- **NCT ID:** NCT06308874
- **Lead sponsor:** J2H Biotech
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-02
- **Primary completion:** 2023-02-17
- **Final completion:** 2023-02-17
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06308874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06308874, "Investigate Safety, Tolerability, PK/PD of J2H-1702 in Healthy Females". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06308874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*